Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: The ROSE acute heart failure randomized trial

JAMA

Volumn 310, Issue 23, 2013, Pages 2533-2543

  Chen, Horng H ^a   Anstrom, Kevin J ^b   Givertz, Michael M ^c   Stevenson, Lynne W ^c   Semigran, Marc J ^d   Goldsmith, Steven R ^e   Bart, Bradley A ^e   Bull, David A ^f   Stehlik, Josef ^f   LeWinter, Martin M ^g   Konstam, Marvin A ^h   Huggins, Gordon S ^h   Rouleau, Jean L ⁱ   O'Meara, Eileen ⁱ   Tang, W H Wilson ^j   Starling, Randall C ^j   Butler, Javed ^k   Deswal, Anita ^l   Felker, G Michael ^m   O'Connor, Christopher M ^m   Bonita, Raphael E ⁿ   Margulies, Kenneth B ^o   Cappola, Thomas P ^o   Ofili, Elizabeth O ^p   Mann, Douglas L ^q   Dávila Román, Victor G ^q   McNulty, Steven E ^b   Borlaug, Barry A ^a   Velazquez, Eric J ^m   Lee, Kerry L ^b   Shah, Monica R ^r   Hernandez, Adrian F ^b   Braunwald, Eugene ^c   Redfield, Margaret M ^a   more..

^a MAYO CLINIC   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HENNEPIN COUNTY MEDICAL CENTER   (United States)

^f UNIVERSITY OF UTAH   (United States)

^g UNIVERSITY OF VERMONT   (United States)

^h TUFTS MEDICAL CENTER   (United States)

ⁱ MONTREAL HEART INSTITUTE   (Canada)

^j LERNER RESEARCH INSTITUTE   (United States)

^k EMORY UNIVERSITY   (United States)

^l BAYLOR COLLEGE OF MEDICINE   (United States)

^m DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁿ THOMAS JEFFERSON UNIVERSITY   (United States)

^o UNIVERSITY OF PENNSYLVANIA   (United States)

^p MOREHOUSE SCHOOL OF MEDICINE   (United States)

^q WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; CYSTATIN C; DOPAMINE; FUROSEMIDE; LOOP DIURETIC AGENT; NESIRITIDE; NITROGEN; PLACEBO; SODIUM; UREA;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CARDIORENAL SYNDROME; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HOSPITAL PATIENT; HUMAN; HYPOTENSION; KIDNEY DYSFUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; UREA NITROGEN BLOOD LEVEL; URINE VOLUME; WEIGHT CHANGE;

EID: 84890369206     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.282190     Document Type: Article

References (26)

1. Lindenfeld J, Albert NM, Boehmer JP, et al Heart Failure Society of America. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail. 2010;16(6):e1-e194.
2. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;3. doi:10.1161/CIR.0b013e31829e8776.
3. Ronco C, McCullough P, Anker SD, et al Acute Dialysis Quality Initiative (ADQI) Consensus Group. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur Heart J. 2010;31(6):703-711.
4. Givertz MM, Teerlink JR, Albert NM, et al. Acute decompensated heart failure: update on new and emerging evidence and directions for future research. J Card Fail. 2013;19(6):371-389.
5. Maskin CS, Ocken S, Chadwick B, LeJemtel TH. Comparative systemic and renal effects of dopamine and angiotensin-converting enzyme inhibition with enalaprilat in patients with heart failure. Circulation. 1985;72(4):846-852.
6. Elkayam U, Ng TM, Hatamizadeh P, Janmohamed M, Mehra A. Renal vasodilatory action of dopamine in patients with heart failure: magnitude of effect and site of action. Circulation. 2008;117(2):200-205.
7. Cotter G, Weissgarten J, Metzkor E, et al. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther. 1997;62(2):187-193.
8. Varriale P, Mossavi A. The benefit of low-dose dopamine during vigorous diuresis for congestive heart failure associated with renal insufficiency: does it protect renal function? Clin Cardiol. 1997;20(7):627-630.
9. Giamouzis G, Butler J, Starling RC, et al. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial. J Card Fail. 2010;16(12):922-930.
10. Chen HH, Burnett JC Jr. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials. Proc Assoc Am Physicians. 1999;111(5):406-416.
11. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287(12):1531-1540.
12. O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011;365(1):32-43.
13. Chen HH, Cataliotti A, Schirger JA, Martin FL, Harstad LK, Burnett JC Jr. Local renal delivery of a natriuretic peptide: a renal-enhancing strategy for B-type natriuretic peptide in overt experimental heart failure. J Am Coll Cardiol. 2009;53(15):1302- 1308.
14. Chen HH, Sundt TM, Cook DJ, Heublein DM, Burnett JC Jr. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study. Circulation. 2007;116(11)(suppl):I134-I138.
15. Riter HG, Redfield MM, Burnett JC, Chen HH. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction. J Am Coll Cardiol. 2006;47(11):2334-2335.
16. Chen HH, Abouezzeddine OF, Anstrom KJ, et al Heart Failure Clinical Research Network. Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) Trial. Circ Heart Fail. 2013;6(5):1087-1094.
17. Felker GM, Lee KL, Bull DA, et al NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364(9):797-805.
18. Owan TE, Chen HH, Frantz RP, et al. The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction. J Card Fail. 2008;14(4):267-275.
19. Bart BA, Goldsmith SR, Lee KL, et al Heart Failure Clinical Research Network. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012;367(24):2296-2304.
20. Metra M, Cotter G, Davison BA, et al RELAX-AHF Investigators. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol. 2013;61(2):196-206.
21. Teerlink JR, Cotter G, Davison BA, et al Relaxin in Acute Heart Failure (RELAX-AHF) Investigators. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet. 2013;381(9860):29-39.
22. Massie BM, O'Connor CM, Metra M, et al PROTECT Investigators and Committees. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med. 2010;363(15): 1419-1428.
23. Gottlieb SS, Stebbins A, Voors AA, et al. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure). J Am Coll Cardiol. 2013;62(13):1177-1183.
24. Wang DJ, Dowling TC, Meadows D, et al. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation. 2004;110(12):1620- 1625.
25. Hauptman PJ, Swindle J, Burroughs TE, Schnitzler MA. Resource utilization in patients hospitalized with heart failure: insights from a contemporary national hospital database. Am Heart J. 2008;155(6):978-985.e1.
26. Schwartzenberg S, Redfield MM, From AM, Sorajja P, Nishimura RA, Borlaug BA. Effects of vasodilation in heart failure with preserved or reduced ejection fraction: implications of distinct pathophysiologies on response to therapy. J Am Coll Cardiol. 2012;59(5):442-451.